Evidence map›Paper›PMID 24703341›Full record

ReviewRheumatic diseases clinics of North America2014

Epidemiology of gout.

Edward Roddy, Hyon K Choi

Open access · greenAbstract readReview
In one paragraph

Review in Rheumatic diseases clinics of North America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 7 pooled it
31.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 7 syntheses or guidelines pooled it, 475 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. A meta-analysis of the associations between the Q141K and Q126X ABCG2 gene variants and gout risk.International journal of clinical and experimental pathology · 2015
    Pooled it
  8. Trial
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Edward RoddyResearch Institute for Primary Care and Health Sciences, Keele University, Keele, Staffordshire ST5 5BG, UK. Electronic address: e.roddy@keele.ac.uk.
Hyon K ChoiSection of Rheumatology and Clinical Epidemiology Unit, Boston University School of Medicine, 650 Albany Street, Suite 200, Boston, MA 02118, USA.
Boston University · USKeele University · GB

Funding

NOVEL METABOLITE AND MICROBIOTA PATHWAYS FOR HYPERURICEMIA AND GOUTR01AR065944 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI CHOI, HYON K · 2013 to 2025
$4.2M
Genetics of GoutR01AR056291 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, HYON K · 2008 to 2011
$2.9M
Risk Factors for Gout Among WomenR21AR056042 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, HYON K · 2008 to 2009
$424k
NIAMS NIH HHS R01 AR056291NIAMS NIH HHS R01 AR065944NIAMS NIH HHS R21 AR056042
6 · The paper itself

Abstract

Gout is the most prevalent inflammatory arthritis in men. The findings of several epidemiologic studies from a diverse range of countries suggest that the prevalence of gout has risen over the past few decades. Although incidence data are scarce, data from the United States suggests that the incidence of gout is also rising. Evidence from prospective epidemiologic studies has confirmed dietary factors (animal purines, alcohol, and fructose), obesity, the metabolic syndrome, hypertension, diuretic use, and chronic kidney disease as clinically relevant risk factors for hyperuricemia and gout. Low-fat dairy products, coffee, and vitamin C seem to have a protective effect.

Indexed as

Feeding BehaviorAdrenergic beta-AntagonistsAngiotensin Receptor AntagonistsDiureticsGoutHumansHypertensionHyperuricemiaIncidenceKidney Failure, ChronicMetabolic SyndromeObesityPrevalenceProtective FactorsRisk FactorsUnited StatesAdrenergic beta-AntagonistsAngiotensin Receptor AntagonistsDiureticsEpidemiologyEtiologyGoutHyperuricemiaIncidencePrevalence

Identifiers

PMID24703341
PMCPMC4119792
OpenAlexW1987339529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.